Abstract
The association between plasminogen activator inhibitor-1 (PAI-1) 4G/5G gene polymorphism and immunoglobulin A nephropathy (IgAN) risk is still controversial. A meta-analysis was performed to evaluate the association between PAI-1 4G/5G gene polymorphism and IgAN susceptibility. A predefined literature search and selection of eligible relevant studies were performed to collect data from electronic database. Four articles were identified for the analysis of association between PAI-1 4G/5G gene polymorphism and IgAN risk. 4G allele was not associated with IgAN susceptibility in overall populations and in Asians. Furthermore, 4G/4G and 5G/5G genotype were not associated with IgAN for overall populations, Asians. In conclusion, PAI-1 4G/5G gene polymorphism was not associated with IgAN risk in overall populations and in Asians. However, more studies should be performed in the future.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.